Superoxide-mediated phosphorylation and stabilization of Mcl-1 by AKT underlie venetoclax resistance in hematologic

Stephen J F Chong1,2,3,4, Jolin X H Lai5, Kartini Iskandar5

  • 1Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore (NUS), Singapore, Singapore. SJFChong@nus.edu.sg.

Leukemia
|July 24, 2025
PubMed

Insights

Venetoclax (VEN) resistance in leukemia involves increased Mcl-1 protein due to elevated superoxide levels. Targeting this redox-dependent Mcl-1 stability with AKT inhibitors restores VEN sensitivity.

Area of Science:

  • Hematologic Malignancies
  • Cancer Cell Biology
  • Drug Resistance Mechanisms

Background:

  • Venetoclax (VEN) resistance is a significant clinical challenge in chronic lymphocytic leukemia and acute myeloid leukemia.
  • Mcl-1 upregulation is a known mechanism of VEN resistance, shifting cell survival dependence from Bcl-2 to Mcl-1.
  • The precise mechanisms driving Mcl-1 upregulation in VEN-resistant cells remain unclear.

Purpose of the Study:

  • To investigate the role of intracellular redox state in Mcl-1 upregulation and Venetoclax (VEN) resistance.
  • To elucidate the signaling pathways connecting cellular redox balance to Mcl-1 protein stability.
  • To explore therapeutic strategies targeting the identified VEN resistance mechanism.

Main Methods:

  • Analysis of intracellular superoxide (O2.-) levels in VEN-sensitive and VEN-resistant hematologic malignant cells.
  • Assessment of Mcl-1 protein levels, phosphorylation (T163pMcl-1), ubiquitination, and degradation.
  • Pharmacological inhibition of AKT/PKB signaling and redox modulation.
  • Evaluation of combination therapy efficacy in a murine model of VEN-resistant leukemia.

Main Results:

  • VEN-resistant cells exhibit significantly elevated intracellular superoxide (O2.-) levels.
  • Increased O2.- augments Mcl-1 protein stability by promoting T163 phosphorylation and reducing degradation.
  • Redox-activated AKT/PKB signaling is crucial for O2.--induced Mcl-1 stabilization.
  • Inhibition of AKT or reduction of O2.- restores VEN sensitivity by increasing apoptotic priming.
  • Combination therapy with capivasertib (AKT inhibitor) and VEN reduced tumor burden and prolonged survival in mice.

Conclusions:

  • A novel redox-dependent mechanism contributes to Mcl-1 stability and Venetoclax (VEN) resistance in hematologic malignancies.
  • Intracellular superoxide levels and AKT signaling are key regulators of Mcl-1 stability in this context.
  • Targeting redox pathways and AKT offers a promising therapeutic strategy to overcome VEN resistance.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
15.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.0K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.9K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.8K